Archive | Redefining Every Stage Investments (RESI) RSS feed for this section

The Right Place to Meet with Real Investors – Here’s Why Startups Attend RESI

6 Apr

By Karen Deyo, Director of Investor Research, Israel BD, LSN

RESI continues to be successful with a global gathering of early-stage startups, as well as the investors and strategic partners looking to invest in them. Participants from more than 30 countries on 5 continents attended RESI in the past year. Whether it is an in-person or a virtual, each RESI has 1,000+ partnering meetings booked. Individual companies have booked up to 40 meetings over the course of the conference, with more than 75% of meetings booked occurring between companies and investors.

RESI-Partnering-Meeting-Breakdown

In addition to an extremely active partnering platform, the panels, workshops, and pitch sessions are well-attended and dynamic, with enthusiastic audience participation. We’ll continue to serve life science startups all this great content and provide a wonderful partnering experience in the upcoming RESI Boston June 5-7, with one day in person (June 5) at The Westin Copley Place in Boston, followed by two days (June 6-7) of virtual partnering only. Make sure to register by Friday, April 7th for Super Early Bird tickets to save $500!

RESI-Boston-2023-June-1100px

Global Target List – Key to a Successful Fundraise

6 Apr

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

Every successful entrepreneur will tell you that you have to kiss a lot of frogs before you find discover your prince. Or put more directly, you need to talk to a lot of potential investors and/or licensing partners in order to close a funding round. It really is a numbers game. But how do you identify the hundreds of investment firms out there that would be a fit for your product and stage of development?

LSN has been helping early-stage life science companies develop their Global Target List (GTL) of investors for over 10 years now, based on a couple of very basic premises:

  1. Your GTL must be exclusively based on fit.
  2. If you have your story straight and have the right tools to present it, you can reach out to your GTL without a warm referral.

A great source for your GTL that LSN has been curating for over 10 years is the LSN Investor Database, tracking 3,000+ investment firms and over 10,000 contacts. Once you filter for your technology and stage of development, you will generate a list of hundreds of investors and licensing partners who are a fit.

COMING SOON:

FREE_WEBINAR_APRIL_12

LSN is continuously looking for ways to improve our offerings to startups by way of new tools and services. Very soon we will be announcing the launch of the GLOBAL PARTNERING CAMPAIGN app, a custom app in a CRM (Customer Relationship Management) program that will combine the benefits of using a CRM to organize your outreach with the powerful LSN Investor Database. Some functions of the platform that will help you stay organized:

  • Create your Global Target List from the LSN Database
  • Track all of your activities (emails, calls, meeting) with each investor automatically
  • Run reports and generate lists for specific activities
  • Set task reminders for each investor

If you would like to learn more and see what your own GTL would look like in the LSN Investor Database, just book a meeting with our BD Team below.

Life Science Nation Business Development Team
International
East Coast (USA) & China
Midwest (USA)
& Canada
West Coast  (USA)
Cameron-Hurlburt
Greg Mannix
Vice President International Business Development
Book a Meeting
Email Me
Candice He
VP, Business Development & Global Investment Strategist
Book a Meeting
Email Me
Antoinette Lowre
Manager of Business Development
Book a Meeting
Email Me
Cameron Hurlburt
Manager of Business Development
Book a Meeting
Email Me

RESI Boston June Investor Panel Line-up

30 Mar

By Momo Yamamoto, Investor Research Analyst, LSN

RESI Boston June will be back again at The Westin Copley Place on June 5th in-person followed by virtual partnering on June 6th – 7th. The RESI Conference will continue to highlight the Innovator’s Pitch Challenge, educational workshops, and 7 investor panels with investors and strategic partners providing the latest insights to conference attendees.

RESI Boston June will feature a variety of topics for our investor panels, including popular panels such as Big Pharma, Corporate Venture Capital, and MedTech Strategics. Life Science Nation is also excited to introduce new investor panels: Women’s Health and CNS Diseases. All of the panels, new and old, will highlight current industry trends and provide valuable advice from investors and strategic partners to help entrepreneurs with their fundraising efforts. Make sure to register by Friday, April 7th for Super Early Bird tickets to save $500!

Register-now-button-new

RESI-June-Investor-Panel-Agenda

RESI-Boston-2023-June-1100px

LSN: 10 Years Connecting Players In the Life Sciences

30 Mar

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

At Life Science Nation (LSN) for the past 10 years, we have been connecting early-stage companies with investors and licensing partners who are a fit for their technology and stage of development. We saw that startups were struggling to identify the right partners outside of their immediate communities and really needed a conduit to the rest of the world. Fast forward 10 years and LSN is helping to make those connections in an array of different ways!

Watch the video below to learn more about the LSN story.

LSN Entrepreneurial Education Program at BioMedSA

30 Mar

By Erika Wu, Business Development Manager, Global Tech Hubs, LSN

Life Science Nation (LSN) will be delivering an Entrepreneurial Education Workshop in concert with BioMedSA’s annual event, BioFest Invest! BioFest Invest will held on Wednesday, April 19th at the University of the Incarnate Word, and will feature programming topics relevant to life science entrepreneurs, a pitch competition, and networking opportunities with a wide array of resources and potential collaborative partners and investors.

During the week leading up to the event, on Thursday, April 13th, LSN will be hosting a one-day educational course for a group of BioMedSA’s fundraising startups who will be attending and pitching at BioFest Invest. This LSN one-day education course will be hosted by LSN’s CEO, Dennis Ford, and Business Development Manager, Antoinette Lowre, and will feature three lectures and 1 on 1 coaching sessions revolving around developing a compelling storyline and netting out the value of the founders, team, technology and market impact.

Entrepreneurial Education Courses at BioMedSA

1. It All Starts with The Story

The most successful entrepreneurs are always the best storytellers. Finding a way to naturally formulate your company’s unique story and portraying this through multiple modalities whether it be a 1-minute elevator pitch or a 12-slide pitch deck is one of the most effective ways to get potential investors and partners on board with your value proposition. This bootcamp will cover the importance of entrepreneurial agency, finding your voice and developing a compelling narrative for the different players that will emerge along a deal chain, and language tools to refine your hook.

2. First-Time CEOs: Avoiding Pitfalls

This session will cover some of the most common pitfalls that catch first-time and serial entrepreneurs off guard. From false premise and being tentative to surrounding yourself with executives that do not have augmentative and complimentary skillsets, there are many things that can slow the growth of your early-stage life science entity. By learning how to avoid these issues and not run yourself over, your chances of making it to the market will increase greatly.

3. Branding & Messaging

Discuss the importance of preparing, planning and executing a global fundraising or licensing campaign. Learn how to position and pitch your company by telling your story and communicating effectively through a tagline, elevator pitch, tear sheet, executive summary, and slide deck.
1-1 sessions to perfect your story and marketing materials.

If you have any questions about hosting an LSN education course, or are interested in meeting LSN in San Antonio, Texas, please contact Antoinette Lowre.

RESI-Boston-2023-June-1100px

Congratulations to the IPC Winners, Next Up RESI Boston, June 5-7

22 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Congratulations to all Innovator’s Pitch Challenge (IPC) finalists that participated in Digital RESI March last week. During the 3-day virtual conference, 30+ pitch companies were featured on a dedicated landing page that hosted their supplementary materials and participated in a live Q&A session with a panel of judges, who are active investors or industry experts in the space. They presented their unique and innovative technologies and products to the RESI attendees, and these technologies and products represent the future of life science arena. RESI attendees voted for their favorite pitch companies. Congratulations to the three IPC winners!

1st Place

Recognized as the 2022 Top Emerging Company at BIO International, SiVEC Biotechnologies has developed BactPac™, a live biotherapeutic delivery platform to enable the next generation of nucleic acid and gene editing therapies. BactPac is engineered to produce therapeutic payloads (mRNA, siRNA, proteins, and CRISPR/Cas) and safely deliver these payloads to targeted tissues (e.g., pancreas, lungs, heart and brain) that cannot be targeted by viral vectors and lipid nanoparticles (LNPs). BactPac can generate large and varied therapeutic moieties that have applications in a wide range of disease indications, including cancer, genetic, infectious, and chronic diseases. Using the BactPac platform, SiVEC is developing a first-in-class therapeutic pipeline targeting a range of therapeutic areas, including oncology, respiratory diseases, and rare genetic diseases. SiVEC has secured nearly $4M in NIH SBIR funding, has a strong patent portfolio, and has an early collaboration with a gene-editing company. We are seeking a $7M seed investment.

Check Out SiVEC Biotechnologies’ Dedicated Page

2nd Place

Reglagene is a therapeutics company dedicated to developing transformational therapies for brain diseases. Reglagene’s product RGN6024 demonstrated proof of concept, safely shrinking tumors in a therapy resistant animal model of brain cancer and beating todays standard of care head-to-head. RGN6024 is the subject of a 2023 patent filing, has a concise manufacturing process, and a risk-mitigating, diversified clinical development plan. We anticipate the start of human clinical trials in mid 2024. Reglagene’s second product in development leverages what we’ve learned from RGN6024 biology to target diseases driven by neuroinflammation, such as Parkinson’s Disease.

Check Out Reglagene’s Dedicated Page

3rd Place

Amplified Sciences is a clinical stage life science in-vitro diagnostics company with an ultra-sensitive molecular-sensing platform technology with composition of matter IP exclusively licensed from Purdue University focused on accurately detecting debilitating diseases sooner. Their lead assay for early detection of pancreatic cancer is supported with clinical published data and provides increased accuracy and earlier detection helping gastroenterologists stratify patients at risk for pancreatic cancer. Open $3M Series Seed Preferred, led by OCA Ventures and Elevate Ventures will fund opening of clinical lab, CLIA regulatory milestone, and support commercial launch in 2023 as well as scale additional assays on their ultrasensitive chemistry reagent platform.

Check Out Amplified Sciences’ Dedicated Page

The show never stops. If you missed the opportunity to pitch in March, applications are now open for RESI Boston, June 5-7. Apply to pitch in-person pitch on June 5. RESI Boston June is a hybrid format conference starting with a one day (June 5) in-person conference experience including partnering meeting, investor panels, IPC, workshops and Global Partnering Campaign and Roadshow Preparation classes at The Westin Copley Place in Boston, MA. Followed by two days (June 6-7) of a virtual partnering only event. Pitch applications are accepted on a rolling basis, so get yours in today!

Apply-for-the-IPC

Application deadline is Friday, April 21.

Want to be part of RESI Boston June? Register now to save $500 on super early bird rates by April 7. RESI also provides sponsorship and exhibition opportunities to help you increase your brand visibility at RESI Boston June or any future RESI conferences, contact us to learn more.

RESI-Boston-2023-June-1100px

Digital RESI March – A Tailor Made Conference for Early-Stage Life Science Fundraising Startups

9 Mar

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

Digital RESI March is merely days away, and It’s never too late for you to catch this terrific opportunity to meet with 250+ early-stage investors and licensing partners at a fraction of the overall cost of attending an in-person event. Fundraising is a numbers game and deals can take up to 9-18 months, so meeting with investors frequently can give you a competitive edge. Not only with partnering, in addition digital RESI March is designed with high-quality panels, pitch sessions, and Global Partnering Campaign and Roadshow Preparation Courses.

1:1 Partnering

LSN expects 250+ global investors at digital RESI March seeking new technology assets for their portfolios. LSN’s partnering events are international in scope and include companies across the silos of drugs, devices, diagnostics, digital health and R&D / life science tools. With the most powerful partnering platform RESI can match companies and partners based on stage of development and product fit.

Investor Panels & Workshops

Check out our impressive panels aimed at aiding early-stage CEOs as they navigate the fundraising landscape, while also providing insight for investors and strategic partners into the latest tech and industry developments.

Global Partnering Campaign and Roadshow Preparation Courses

Digital RESI March will feature a novel entrepreneurial education track, the LSN Global Partnering Campaign and Roadshow Preparation course, which will include six classes. This education focus will be for entrepreneurs who are starting to plan for their fundraising and licensing partner search and how LSN can help. An important theme for the education program will concern how to plan and execute a global roadshow efficiently, which can greatly determine an early-stage entity’s success when moving from their regional environment to the global competitive landscape.

Innovator’s Pitch Challenge

34 life science innovators’ representing therapeutics, medical devices, diagnostics, digital health, and R&D / life science tools will be delivering a short pitch followed by a Q&A session with a panel of investors and industry experts. At the meantime, the companies will have a dedicated landing page, including non-confidential materials of their company, that will be showcased to all RESI attendees as a way for participating companies to boost their exposure.

We look forward to seeing you at RESI next week! You can still register for the conference and engage in partnering meetings with attendees of interest, and join our robust program of investor panels, Entrepreneurial Education Courses, and pitch sessions.

RESI-March-Agenda-03092023

RESI-Boston-2023-June-1100px-border

← Older Entries
Newer Entries →